Semi-Annual Consolidated Statement Of Income

JCR Pharmaceuticals Co.,Ltd. - Filing #7251173

Concept 2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
Semi-annual consolidated statement of income
Statement of income
Net sales
33,072,000,000 JPY
33,071,000,000 JPY
42,871,000,000 JPY
42,871,000,000 JPY
Cost of sales
11,333,000,000 JPY
11,334,000,000 JPY
11,620,000,000 JPY
11,620,000,000 JPY
Gross profit (loss)
21,738,000,000 JPY
21,737,000,000 JPY
31,251,000,000 JPY
31,250,000,000 JPY
Ordinary profit (loss)
-7,477,000,000 JPY
-7,569,000,000 JPY
7,264,000,000 JPY
8,048,000,000 JPY
Extraordinary income
1,065,000,000 JPY
1,043,000,000 JPY
0 JPY
0 JPY
Selling, general and administrative expenses
Depreciation
825,000,000 JPY
810,000,000 JPY
Selling, general and administrative expenses
28,389,000,000 JPY
28,638,000,000 JPY
23,719,000,000 JPY
23,701,000,000 JPY
Extraordinary losses
2,000,000 JPY
2,000,000 JPY
20,000,000 JPY
20,000,000 JPY
Profit (loss) before income taxes
-6,414,000,000 JPY
-6,528,000,000 JPY
7,244,000,000 JPY
8,028,000,000 JPY
Operating profit (loss)
-6,650,000,000 JPY
-6,900,000,000 JPY
7,531,000,000 JPY
7,549,000,000 JPY
Income taxes - current
52,000,000 JPY
-11,000,000 JPY
1,788,000,000 JPY
1,743,000,000 JPY
Non-operating income
Interest income
113,000,000 JPY
84,000,000 JPY
111,000,000 JPY
98,000,000 JPY
Dividend income
34,000,000 JPY
34,000,000 JPY
26,000,000 JPY
26,000,000 JPY
Non-operating income
260,000,000 JPY
233,000,000 JPY
1,056,000,000 JPY
1,008,000,000 JPY
Non-operating expenses
Interest expenses
155,000,000 JPY
155,000,000 JPY
86,000,000 JPY
84,000,000 JPY
Share of loss of entities accounted for using equity method
467,000,000 JPY
1,090,000,000 JPY
Non-operating expenses
1,088,000,000 JPY
902,000,000 JPY
1,324,000,000 JPY
508,000,000 JPY
Income taxes - deferred
-1,771,000,000 JPY
-1,771,000,000 JPY
-80,000,000 JPY
-80,000,000 JPY
Income taxes
-1,718,000,000 JPY
-1,782,000,000 JPY
1,707,000,000 JPY
1,663,000,000 JPY
Profit (loss)
-4,695,000,000 JPY
-4,746,000,000 JPY
-4,746,000,000 JPY
-4,746,000,000 JPY
-4,746,000,000 JPY
6,364,000,000 JPY
5,536,000,000 JPY
6,364,000,000 JPY
6,364,000,000 JPY
6,364,000,000 JPY
Extraordinary income
Gain on sale of non-current assets
0 JPY
0 JPY
0 JPY
0 JPY
Extraordinary losses
Profit (loss) attributable to non-controlling interests
63,000,000 JPY
28,000,000 JPY
Profit (loss) attributable to owners of parent
-4,759,000,000 JPY
-4,759,000,000 JPY
-4,759,000,000 JPY
5,507,000,000 JPY
5,507,000,000 JPY
5,507,000,000 JPY
Other comprehensive income
Valuation difference on available-for-sale securities
195,000,000 JPY
185,000,000 JPY
Deferred gains or losses on hedges
3,000,000 JPY
0 JPY
Foreign currency translation adjustment
130,000,000 JPY
166,000,000 JPY
Remeasurements of defined benefit plans, net of tax
-78,000,000 JPY
153,000,000 JPY
Share of other comprehensive income of entities accounted for using equity method
401,000,000 JPY
434,000,000 JPY
Other comprehensive income
652,000,000 JPY
939,000,000 JPY
Comprehensive income
-4,043,000,000 JPY
6,475,000,000 JPY
Comprehensive income attributable to
Comprehensive income attributable to owners of parent
-4,139,000,000 JPY
6,430,000,000 JPY
Comprehensive income attributable to non-controlling interests
96,000,000 JPY
44,000,000 JPY
Profit attributable to

Talk to a Data Expert

Have a question? We'll get back to you promptly.